{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T11:40:17Z","timestamp":1794915617061,"version":"4.9.1"},"reference-count":309,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DK115392"],"award-info":[{"award-number":["R01 DK115392"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL153004"],"award-info":[{"award-number":["R01 HL153004"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DK16618"],"award-info":[{"award-number":["R01 DK16618"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL155834"],"award-info":[{"award-number":["R01 HL155834"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013642","name":"Japan Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013642","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["852429"],"award-info":[{"award-number":["852429"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","award":["K23HL159279"],"award-info":[{"award-number":["K23HL159279"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-175027"],"award-info":[{"award-number":["PJT-175027"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000035","name":"Institute of Nutrition, Metabolism and Diabetes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000191","name":"Kidney Foundation of Canada","doi-asserted-by":"publisher","award":["851937-21KHRG"],"award-info":[{"award-number":["851937-21KHRG"]}],"id":[{"id":"10.13039\/501100000191","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Kidney Research Scientist Core Education and National Training","award":["2019KP-NIA626990"],"award-info":[{"award-number":["2019KP-NIA626990"]}]},{"name":"Lorna Jocelyn Wood Chair for Kidney Research"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>We are witnessing a revolution in our understanding of primary aldosteronism (PA). In the past 2 decades, we have learned that PA is a highly prevalent syndrome that is largely attributable to pathogenic somatic mutations, that contributes to cardiovascular, metabolic, and kidney disease, and that when recognized, can be adequately treated with widely available mineralocorticoid receptor antagonists and\/or surgical adrenalectomy. Unfortunately, PA is rarely diagnosed, or adequately treated, mainly because of a lack of awareness and education. Most clinicians still possess an outdated understanding of PA; from primary care physicians to hypertension specialists, there is an urgent need to redefine and reintroduce PA to clinicians with a modern and practical approach. In this state-of-the-art review, we provide readers with the most updated knowledge on the pathogenesis, prevalence, diagnosis, and treatment of PA. In particular, we underscore the public health importance of promptly recognizing and treating PA and provide pragmatic solutions to modify clinical practices to achieve this.<\/jats:p>","DOI":"10.1093\/ajh\/hpac079","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T13:01:24Z","timestamp":1656507684000},"page":"967-988","source":"Crossref","is-referenced-by-count":138,"title":["Primary Aldosteronism: State-of-the-Art Review"],"prefix":"10.1093","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0314-9252","authenticated-orcid":false,"given":"Anand","family":"Vaidya","sequence":"first","affiliation":[{"name":"Department of Medicine, Center for Adrenal Disorders, Brigham and Women\u2019s Hospital, Harvard Medical School , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory L","family":"Hundemer","sequence":"additional","affiliation":[{"name":"Department of Medicine (Division of Nephrology) and the Ottawa Hospital Research Institute, University of Ottawa , Ottawa, Ontario ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutaka","family":"Nanba","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center , Kyoto ,","place":["Japan"]},{"name":"Department of Molecular and Integrative Physiology, University of Michigan , Ann Arbor, Michigan ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasita W","family":"Parksook","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology and Metabolism, and Division of General Internal Medicine, Faculty of Medicine, Chulalongkorn University, and King Chulalongkorn Memorial Hospital, Thai Red Cross Society , Bangkok ,","place":["Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenifer M","family":"Brown","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,6,29]]},"reference":[{"key":"2026041420042985500_CIT0001","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1161\/HYPERTENSIONAHA.121.16498","article-title":"Genetics of primary aldosteronism","volume":"79","author":"Scholl","year":"2022","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0002","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1210\/er.2017-00189","article-title":"Genetic causes of functional adrenocortical adenomas","volume":"38","author":"Zennaro","year":"2017","journal-title":"Endocr Rev"},{"key":"2026041420042985500_CIT0003","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1210\/jc.2009-2010","article-title":"Adrenocortical zonation in humans under normal and pathological conditions","volume":"95","author":"Nishimoto","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0004","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.mce.2013.11.022","article-title":"Development of monoclonal antibodies against human CYP11B1 and CYP11B2","volume":"383","author":"Gomez-Sanchez","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"2026041420042985500_CIT0005","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1210\/jc.2012-3726","article-title":"Histopathological diagnosis of primary aldosteronism using CYP11B2 immunohistochemistry","volume":"98","author":"Nanba","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0006","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1161\/HYPERTENSIONAHA.118.11465","article-title":"Immunohistopathology and steroid profiles associated with biochemical outcomes after adrenalectomy for unilateral primary aldosteronism","volume":"72","author":"Meyer","year":"2018","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0007","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1210\/clinem\/dgaa484","article-title":"International histopathology consensus for unilateral primary aldosteronism","volume":"106","author":"Williams","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0008","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12022-022-09710-8","article-title":"Overview of the 2022 WHO classification of adrenal cortical tumors","volume":"33","author":"Mete","year":"2022","journal-title":"Endocr Pathol"},{"key":"2026041420042985500_CIT0009","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/cen.13442","article-title":"Discordance between imaging and immunohistochemistry in unilateral primary aldosteronism","volume":"87","author":"Nanba","year":"2017","journal-title":"Clin Endocrinol"},{"key":"2026041420042985500_CIT0010","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1210\/jc.2016-4007","article-title":"Genetic and histopathologic intertumor heterogeneity in primary aldosteronism","volume":"102","author":"Omata","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0011","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s12020-017-1295-4","article-title":"Histopathological and genetic characterization of aldosterone-producing adenomas with concurrent subclinical cortisol hypersecretion: a case series","volume":"58","author":"Fallo","year":"2017","journal-title":"Endocrine"},{"key":"2026041420042985500_CIT0012","doi-asserted-by":"crossref","first-page":"4920841","DOI":"10.1155\/2018\/4920841","article-title":"Clinical characteristics of aldosterone- and cortisol-coproducing adrenal adenoma in primary aldosteronism","volume":"2018","author":"Tang","year":"2018","journal-title":"Int J Endocrinol"},{"key":"2026041420042985500_CIT0013","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.12998\/wjcc.v9.i5.1119","article-title":"Primary aldosteronism due to bilateral micronodular hyperplasia and concomitant subclinical Cushing\u2019s syndrome: a case report","volume":"9","author":"Teragawa","year":"2021","journal-title":"World J Clin Cases"},{"key":"2026041420042985500_CIT0014","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12902-021-00818-2","article-title":"Concurrence of overt Cushing\u2019s syndrome and primary aldosteronism accompanied by aldosterone-producing cell cluster in adjacent adrenal cortex: case report","volume":"21","author":"Fushimi","year":"2021","journal-title":"BMC Endocr Disord"},{"key":"2026041420042985500_CIT0015","doi-asserted-by":"crossref","first-page":"K1","DOI":"10.1530\/EJE-16-0262","article-title":"Double adrenocortical adenomas harboring independent KCNJ5 and PRKACA somatic mutations","volume":"175","author":"Nanba","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"2026041420042985500_CIT0016","article-title":"Synchronous aldosterone- and cortisol-producing adrenocortical adenomas diagnosed using CYP11B immunohistochemistry","volume":"7","author":"Stenman","year":"2019","journal-title":"SAGE Open Med Case Rep"},{"key":"2026041420042985500_CIT0017","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13256-020-2353-8","article-title":"Primary aldosteronism concurrent with subclinical Cushing\u2019s syndrome: a case report and review of the literature","volume":"14","author":"Zhang","year":"2020","journal-title":"J Med Case Rep"},{"key":"2026041420042985500_CIT0018","doi-asserted-by":"crossref","first-page":"816754","DOI":"10.3389\/fendo.2022.816754","article-title":"Case report: primary aldosteronism due to bilateral aldosterone-producing micronodules with HISTALDO classical and contralateral non-classical pathology","volume":"13","author":"Chen","year":"2022","journal-title":"Front Endocrinol"},{"key":"2026041420042985500_CIT0019","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12902-019-0395-y","article-title":"Hypercortisolism and primary aldosteronism caused by bilateral adrenocortical adenomas: a case report","volume":"19","author":"Ren","year":"2019","journal-title":"BMC Endocr Disord"},{"key":"2026041420042985500_CIT0020","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/HYPERTENSIONAHA.118.11086","article-title":"Cellular and genetic causes of idiopathic hyperaldosteronism","volume":"72","author":"Omata","year":"2018","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0021","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1126\/science.1198785","article-title":"K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension","volume":"331","author":"Choi","year":"2011","journal-title":"Science"},{"key":"2026041420042985500_CIT0022","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/ng.2695","article-title":"Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism","volume":"45","author":"Scholl","year":"2013","journal-title":"Nat Genet"},{"key":"2026041420042985500_CIT0023","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1161\/HYPERTENSIONAHA.119.14349","article-title":"Somatic CACNA1H mutation as a cause of aldosterone-producing adenoma","volume":"75","author":"Nanba","year":"2020","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0024","doi-asserted-by":"crossref","first-page":"e06315","DOI":"10.7554\/eLife.06315","article-title":"Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism","volume":"4","author":"Scholl","year":"2015","journal-title":"Elife"},{"key":"2026041420042985500_CIT0025","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41588-018-0048-5","article-title":"CLCN2 chloride channel mutations in familial hyperaldosteronism type II","volume":"50","author":"Scholl","year":"2018","journal-title":"Nat Genet"},{"key":"2026041420042985500_CIT0026","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41588-018-0053-8","article-title":"A gain-of-function mutation in the CLCN2 chloride channel gene causes primary aldosteronism","volume":"50","author":"Fernandes-Rosa","year":"2018","journal-title":"Nat Genet"},{"key":"2026041420042985500_CIT0027","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/ng.2550","article-title":"Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension","volume":"45","author":"Beuschlein","year":"2013","journal-title":"Nat Genet"},{"key":"2026041420042985500_CIT0028","doi-asserted-by":"crossref","first-page":"19546","DOI":"10.1038\/srep19546","article-title":"Activating mutations in CTNNB1 in aldosterone producing adenomas","volume":"6","author":"Akerstrom","year":"2016","journal-title":"Sci Rep"},{"key":"2026041420042985500_CIT0029","doi-asserted-by":"crossref","first-page":"39121","DOI":"10.1038\/srep39121","article-title":"The prevalence of CTNNB1 mutations in primary aldosteronism and consequences for clinical outcomes","volume":"7","author":"Wu","year":"2017","journal-title":"Sci Rep"},{"key":"2026041420042985500_CIT0030","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/s41588-021-00906-y","article-title":"Somatic mutations of GNA11 and GNAQ in CTNNB1-mutant aldosterone-producing adenomas presenting in puberty, pregnancy or menopause","volume":"53","author":"Zhou","year":"2021","journal-title":"Nat Genet"},{"key":"2026041420042985500_CIT0031","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1161\/HYPERTENSIONAHA.118.12070","article-title":"Genetic characteristics of aldosterone-producing adenomas in blacks","volume":"73","author":"Nanba","year":"2019","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0032","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/355262a0","article-title":"A chimaeric 11 beta-hydroxylase\/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension","volume":"355","author":"Lifton","year":"1992","journal-title":"Nature"},{"key":"2026041420042985500_CIT0033","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1507\/endocrj.EJ12-0247","article-title":"KCNJ5 mutations in aldosterone- and cortisol-co-secreting adrenal adenomas","volume":"59","author":"Yamada","year":"2012","journal-title":"Endocr J"},{"key":"2026041420042985500_CIT0034","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1530\/ERC-18-0364","article-title":"Genetics of aldosterone-producing adenomas with pathogenic KCNJ5 variants","volume":"26","author":"Lerario","year":"2019","journal-title":"Endocr Relat Cancer"},{"key":"2026041420042985500_CIT0035","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.mce.2015.04.022","article-title":"Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas","volume":"411","author":"Monticone","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"2026041420042985500_CIT0036","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1210\/jc.2018-00738","article-title":"Aldosterone suppression by dexamethasone in patients with KCNJ5-mutated aldosterone-producing adenoma","volume":"103","author":"Inoue","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0037","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1161\/HYPERTENSIONAHA.119.14177","article-title":"Genetic, cellular, and molecular heterogeneity in adrenals with aldosterone-producing adenoma","volume":"75","author":"De Sousa","year":"2020","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0038","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1210\/en.2011-1733","article-title":"Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis","volume":"153","author":"Oki","year":"2012","journal-title":"Endocrinology"},{"key":"2026041420042985500_CIT0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/JME-15-0324","article-title":"Mutated KCNJ5 activates the acute and chronic regulatory steps in aldosterone production","volume":"57","author":"Hattangady","year":"2016","journal-title":"J Mol Endocrinol"},{"key":"2026041420042985500_CIT0040","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1210\/jc.2016-1700","article-title":"PRKACA somatic mutations are rare findings in aldosterone-producing adenomas","volume":"101","author":"Rhayem","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0041","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1507\/endocrj.EJ15-0642","article-title":"GNAS mutations in adrenal aldosterone-producing adenomas","volume":"63","author":"Nakajima","year":"2016","journal-title":"Endocr J"},{"key":"2026041420042985500_CIT0042","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1210\/jc.2018-01004","article-title":"Targeted molecular characterization of aldosterone-producing adenomas in white Americans","volume":"103","author":"Nanba","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0043","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/EJE-21-0031","article-title":"Genetics in Endocrinology: impact of race and sex on genetic causes of aldosterone-producing adenomas","volume":"185","author":"Nanba","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"2026041420042985500_CIT0044","doi-asserted-by":"crossref","first-page":"E4591","DOI":"10.1073\/pnas.1505529112","article-title":"Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands","volume":"112","author":"Nishimoto","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026041420042985500_CIT0045","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1210\/js.2017-00134","article-title":"Aldosterone-producing cell clusters frequently harbor somatic mutations and accumulate with age in normal adrenals","volume":"1","author":"Omata","year":"2017","journal-title":"J Endocr Soc"},{"key":"2026041420042985500_CIT0046","doi-asserted-by":"crossref","first-page":"7834356","DOI":"10.1155\/2016\/7834356","article-title":"Human adrenocortical remodeling leading to aldosterone-producing cell cluster generation","volume":"2016","author":"Nishimoto","year":"2016","journal-title":"Int J Endocrinol"},{"key":"2026041420042985500_CIT0047","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1161\/CIRCULATIONAHA.117.028201","article-title":"Age-related autonomous aldosteronism","volume":"136","author":"Nanba","year":"2017","journal-title":"Circulation"},{"key":"2026041420042985500_CIT0048","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1161\/HYPERTENSIONAHA.117.10391","article-title":"Aging and adrenal aldosterone production","volume":"71","author":"Nanba","year":"2018","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0049","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1161\/HYPERTENSIONAHA.118.11243","article-title":"Aldosterone and 18-oxocortisol coaccumulation in aldosterone-producing lesions","volume":"72","author":"Sugiura","year":"2018","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0050","doi-asserted-by":"crossref","first-page":"8918","DOI":"10.1021\/acs.analchem.9b00619","article-title":"Tandem mass spectrometry imaging reveals distinct accumulation patterns of steroid structural isomers in human adrenal glands","volume":"91","author":"Takeo","year":"2019","journal-title":"Anal Chem"},{"key":"2026041420042985500_CIT0051","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M20-0065","article-title":"The unrecognized prevalence of primary aldosteronism: a cross-sectional study","volume":"173","author":"Brown","year":"2020","journal-title":"Ann Intern Med"},{"key":"2026041420042985500_CIT0052","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1210\/jc.2015-3285","article-title":"Case report: nodule development from subcapsular aldosterone-producing cell clusters causes hyperaldosteronism","volume":"101","author":"Nishimoto","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0053","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.mce.2016.10.014","article-title":"Immunohistochemistry of aldosterone synthase leads the way to the pathogenesis of primary aldosteronism","volume":"441","author":"Nishimoto","year":"2017","journal-title":"Mol Cell Endocrinol"},{"key":"2026041420042985500_CIT0054","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1161\/HYPERTENSIONAHA.119.14041","article-title":"Mass spectrometry imaging establishes 2 distinct metabolic phenotypes of aldosterone-producing cell clusters in primary aldosteronism","volume":"75","author":"Sun","year":"2020","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0055","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.molmed.2020.05.005","article-title":"Genetic and genomic mechanisms of primary aldosteronism","volume":"26","author":"Fernandes-Rosa","year":"2020","journal-title":"Trends Mol Med"},{"key":"2026041420042985500_CIT0056","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.1210\/jc.2016-1874","article-title":"Aldosterone-producing adenoma with a somatic KCNJ5 mutation revealing APC-dependent familial adenomatous polyposis","volume":"101","author":"Vouillarmet","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0057","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1210\/clinem\/dgaa703","article-title":"Aldosterone is aberrantly regulated by various stimuli in a high proportion of patients with primary aldosteronism","volume":"106","author":"St-Jean","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0058","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.beem.2018.01.003","article-title":"Aberrant G-protein coupled hormone receptor in adrenal diseases","volume":"32","author":"St-Jean","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0059","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1055\/a-1119-1063","article-title":"Role of mast cells in the control of aldosterone secretion","volume":"52","author":"Lopez","year":"2020","journal-title":"Horm Metab Res"},{"key":"2026041420042985500_CIT0060","article-title":"Colocalization of Wnt\/beta-catenin and ACTH signaling pathways and paracrine regulation in aldosterone producing adenoma","author":"De Sousa","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0061","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1161\/CIRCULATIONAHA.115.018226","article-title":"Adipocyte-derived hormone leptin is a direct regulator of aldosterone secretion, which promotes endothelial dysfunction and cardiac fibrosis","volume":"132","author":"Huby","year":"2015","journal-title":"Circulation"},{"key":"2026041420042985500_CIT0062","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fendo.2016.00072","article-title":"Role of ACTH and other hormones in the regulation of aldosterone production in primary aldosteronism","volume":"7","author":"El Ghorayeb","year":"2016","journal-title":"Front Endocrinol"},{"key":"2026041420042985500_CIT0063","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/j.1365-2362.2011.02531.x","article-title":"High prevalence of autonomous aldosterone secretion among patients with essential hypertension","volume":"41","author":"Gouli","year":"2011","journal-title":"Eur J Clin Invest"},{"key":"2026041420042985500_CIT0064","doi-asserted-by":"crossref","first-page":"644382","DOI":"10.3389\/fendo.2021.644382","article-title":"Aldosterone-regulating receptors and aldosterone-driver somatic mutations","volume":"12","author":"Lim","year":"2021","journal-title":"Front Endocrinol"},{"key":"2026041420042985500_CIT0065","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1210\/jc.2015-1268","article-title":"Stress-induced aldosterone hyper-secretion in a substantial subset of patients with essential hypertension","volume":"100","author":"Markou","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0066","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fendo.2016.00040","article-title":"The potential of ACTH in the genesis of primary aldosteronism","volume":"7","author":"Funder","year":"2016","journal-title":"Front Endocrinol"},{"key":"2026041420042985500_CIT0067","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1210\/jc.2018-00087","article-title":"Genetic characterization of GnRH\/LH-responsive primary aldosteronism","volume":"103","author":"Gagnon","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0068","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1210\/clinem\/dgab707","article-title":"Colocalization of Wnt\/beta-catenin and ACTH signaling pathways and paracrine regulation in aldosterone-producing adenoma","volume":"107","author":"De Sousa","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0069","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1210\/jc.2008-1340","article-title":"Regulation of aldosterone secretion by several aberrant receptors including for glucose-dependent insulinotropic peptide in a patient with an aldosteronoma","volume":"94","author":"Lampron","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0070","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1530\/EJE-08-0711","article-title":"Screening for membrane hormone receptor expression in primary aldosteronism","volume":"160","author":"Zwermann","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"2026041420042985500_CIT0071","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/archinte.1987.00370070103015","article-title":"Secondary hypertension in a blood pressure clinic","volume":"147","author":"Sinclair","year":"1987","journal-title":"Arch Intern Med"},{"key":"2026041420042985500_CIT0072","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa033263","article-title":"Serum aldosterone and the incidence of hypertension in nonhypertensive persons","volume":"351","author":"Vasan","year":"2004","journal-title":"N Engl J Med"},{"key":"2026041420042985500_CIT0073","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/01.HYP.0000258554.87444.91","article-title":"Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample","volume":"49","author":"Newton-Cheh","year":"2007","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0074","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1210\/jc.2012-3353","article-title":"Evidence of primary aldosteronism in a predominantly female cohort of normotensive individuals: a very high odds ratio for progression into arterial hypertension","volume":"98","author":"Markou","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0075","doi-asserted-by":"crossref","first-page":"630","DOI":"10.7326\/M17-0882","article-title":"The spectrum of subclinical primary aldosteronism and incident hypertension","volume":"167","author":"Brown","year":"2017","journal-title":"Ann Intern Med"},{"key":"2026041420042985500_CIT0076","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1161\/HYPERTENSIONAHA.116.08952","article-title":"Continuum of renin-independent aldosteronism in normotension","volume":"69","author":"Baudrand","year":"2017","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0077","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/HYPERTENSIONAHA.120.15006","article-title":"Serum aldosterone concentration, blood pressure, and coronary artery calcium: the multi-ethnic study of atherosclerosis","volume":"76","author":"Inoue","year":"2020","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0078","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice","volume":"69","author":"Monticone","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026041420042985500_CIT0079","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1210\/jc.2016-1963","article-title":"Dietary sodium restriction increases the risk of misinterpreting mild cases of primary aldosteronism","volume":"101","author":"Baudrand","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0080","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1210\/er.2018-00139","article-title":"The expanding spectrum of primary aldosteronism: implications for diagnosis, pathogenesis, and treatment","volume":"39","author":"Vaidya","year":"2018","journal-title":"Endocr Rev"},{"key":"2026041420042985500_CIT0081","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.4158\/E161332.OR","article-title":"Prevalence of primary aldosteronism in an urban hypertensive population","volume":"22","author":"Galati","year":"2016","journal-title":"Endocr Pract"},{"key":"2026041420042985500_CIT0082","doi-asserted-by":"crossref","first-page":"408","DOI":"10.5694\/mja2.51438","article-title":"Detecting primary aldosteronism in Australian primary care: a prospective study","volume":"216","author":"Libianto","year":"2022","journal-title":"Med J Aust"},{"key":"2026041420042985500_CIT0083","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.jacc.2020.02.052","article-title":"Primary aldosteronism in patients in China with recently detected hypertension","volume":"75","author":"Xu","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026041420042985500_CIT0084","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1440-1681.1994.tb02519.x","article-title":"High incidence of primary aldosteronism in 199 patients referred with hypertension","volume":"21","author":"Gordon","year":"1994","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2026041420042985500_CIT0085","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1093\/clinchem\/48.11.1919","article-title":"Screening for primary aldosteronism: implications of an increased plasma aldosterone\/renin ratio","volume":"48","author":"Schwartz","year":"2002","journal-title":"Clin Chem"},{"key":"2026041420042985500_CIT0086","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.119.14063","article-title":"Prevalence of hypokalemia and primary aldosteronism in 5100 patients referred to a tertiary hypertension unit","author":"Burrello","year":"2020","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0087","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.2003-031337","article-title":"Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents","volume":"89","author":"Mulatero","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0088","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2026041420042985500_CIT0089","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","article-title":"Hyperaldosteronism among black and white subjects with resistant hypertension","volume":"40","author":"Calhoun","year":"2002","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0090","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(08)60834-X","article-title":"Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study","volume":"371","author":"Douma","year":"2008","journal-title":"Lancet"},{"key":"2026041420042985500_CIT0091","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1097\/HJH.0000000000002441","article-title":"Prevalence of primary aldosteronism and association with cardiovascular complications in patients with resistant and refractory hypertension","volume":"38","author":"Parasiliti-Caprino","year":"2020","journal-title":"J Hypertens"},{"key":"2026041420042985500_CIT0092","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/cen.14598","article-title":"Prevalence of primary aldosteronism in type 2 diabetes mellitus and hypertension: a prospective study from Western India","volume":"96","author":"Memon","year":"2022","journal-title":"Clin Endocrinol"},{"key":"2026041420042985500_CIT0093","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1055\/a-1507-5226","article-title":"Prevalence of primary aldosteronism across the stages of hypertension based on a new combined overnight test","volume":"53","author":"Voulgaris","year":"2021","journal-title":"Horm Metab Res"},{"key":"2026041420042985500_CIT0094","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz293","article-title":"Determining the prevalence of primary aldosteronism in patients with new-onset type 2 diabetes and hypertension","volume":"105","author":"Hu","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0095","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1161\/HYPERTENSIONAHA.115.06768","article-title":"Aldosterone induces tissue inhibitor of metalloproteinases-1 expression and further contributes to collagen accumulation: from clinical to bench studies","volume":"67","author":"Hung","year":"2016","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0096","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1161\/HYPERTENSIONAHA.118.12342","article-title":"Aldosterone induces vascular damage","volume":"74","author":"Hung","year":"2019","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0097","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1097\/HJH.0b013e32831286fd","article-title":"Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism","volume":"26","author":"Bernini","year":"2008","journal-title":"J Hypertens"},{"key":"2026041420042985500_CIT0098","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/jch.13585","article-title":"Hypertension with primary aldosteronism is associated with increased carotid intima-media thickness and endothelial dysfunction","volume":"21","author":"Demirkiran","year":"2019","journal-title":"J Clin Hypertens"},{"key":"2026041420042985500_CIT0099","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20205214","article-title":"Endothelial dysfunction in primary aldosteronism","volume":"20","author":"Chen","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2026041420042985500_CIT0100","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz306","article-title":"Arterial wall inflammation and increased hematopoietic activity in patients with primary aldosteronism","volume":"105","author":"van der Heijden","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0101","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41371-020-00426-y","article-title":"Left ventricular remodeling and dysfunction in primary aldosteronism","volume":"35","author":"Tsai","year":"2021","journal-title":"J Hum Hypertens"},{"key":"2026041420042985500_CIT0102","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ando.2020.02.006","article-title":"The cardiovascular consequences of hyperaldosteronism","volume":"82","author":"Rossi","year":"2021","journal-title":"Ann Endocrinol"},{"key":"2026041420042985500_CIT0103","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1161\/HYPERTENSIONAHA.115.07074","article-title":"Aldosterone-induced vascular remodeling and endothelial dysfunction require functional angiotensin type 1a receptors","volume":"67","author":"Briet","year":"2016","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0104","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000345243","article-title":"Vascular actions of aldosterone","volume":"50","author":"Briet","year":"2013","journal-title":"J Vasc Res"},{"key":"2026041420042985500_CIT0105","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1161\/HYPERTENSIONAHA.117.09598","article-title":"Endothelial mineralocorticoid receptor mediates parenchymal arteriole and posterior cerebral artery remodeling during angiotensin II-induced hypertension","volume":"70","author":"Diaz-Otero","year":"2017","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0106","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1161\/HYPERTENSIONAHA.117.10437","article-title":"Smooth muscle cell-mineralocorticoid receptor as a mediator of cardiovascular stiffness with aging","volume":"71","author":"Kim","year":"2018","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0107","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1038\/nm.2891","article-title":"Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors","volume":"18","author":"McCurley","year":"2012","journal-title":"Nat Med"},{"key":"2026041420042985500_CIT0108","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1161\/HYPERTENSIONAHA.115.06172","article-title":"Endothelial mineralocorticoid receptors differentially contribute to coronary and mesenteric vascular function without modulating blood pressure","volume":"66","author":"Mueller","year":"2015","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0109","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3389\/fphar.2017.00313","article-title":"Mineralocorticoid receptor signaling as a therapeutic target for renal and cardiac fibrosis","volume":"8","author":"Tesch","year":"2017","journal-title":"Front Pharmacol"},{"key":"2026041420042985500_CIT0110","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1161\/HYPERTENSIONAHA.108.111369","article-title":"Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients","volume":"51","author":"Rossi","year":"2008","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0111","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0895-7061(02)03021-2","article-title":"Left ventricular changes in primary aldosteronism","volume":"16","author":"Rossi","year":"2003","journal-title":"Am J Hypertens"},{"key":"2026041420042985500_CIT0112","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/01.HYP.0000023182.68420.EB","article-title":"Excess aldosterone is associated with alterations of myocardial texture in primary aldosteronism","volume":"40","author":"Rossi","year":"2002","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0113","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1210\/endo.141.10.7711","article-title":"Aldosterone: a mediator of myocardial necrosis and renal arteriopathy","volume":"141","author":"Rocha","year":"2000","journal-title":"Endocrinology"},{"key":"2026041420042985500_CIT0114","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1161\/hyp.39.2.614","article-title":"Cardiac damage prevention by eplerenone: comparison with low sodium diet or potassium loading","volume":"39","author":"Martinez","year":"2002","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0115","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1161\/HYPERTENSIONAHA.109.141531","article-title":"Rapid reversal of left ventricular hypertrophy and intracardiac volume overload in patients with resistant hypertension and hyperaldosteronism: a prospective clinical study","volume":"55","author":"Gaddam","year":"2010","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0116","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/j.jcmg.2020.06.026","article-title":"Aldosterone-related myocardial extracellular matrix expansion in hypertension in humans: a proof-of-concept study by cardiac magnetic resonance","volume":"13","author":"Redheuil","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026041420042985500_CIT0117","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","article-title":"Cardiovascular outcomes in patients with primary aldosteronism after treatment","volume":"168","author":"Catena","year":"2008","journal-title":"Arch Intern Med"},{"key":"2026041420042985500_CIT0118","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2026041420042985500_CIT0119","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1210\/jc.2013-2805","article-title":"Long-term cardio- and cerebrovascular events in patients with primary aldosteronism","volume":"98","author":"Mulatero","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0120","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/HYPERTENSIONAHA.113.01060","article-title":"Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study","volume":"62","author":"Savard","year":"2013","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0121","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1097\/HJH.0000000000001251","article-title":"Plasma aldosterone level within the normal range is less associated with cardiovascular and cerebrovascular risk in primary aldosteronism","volume":"35","author":"Murata","year":"2017","journal-title":"J Hypertens"},{"key":"2026041420042985500_CIT0122","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/BF03347840","article-title":"Vascular complications in patients with aldosterone producing adenoma in Japan: comparative study with essential hypertension. The Research Committee of Disorders of Adrenal Hormones in Japan","volume":"18","author":"Takeda","year":"1995","journal-title":"J Endocrinol Invest"},{"key":"2026041420042985500_CIT0123","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1161\/HYPERTENSIONAHA.112.197111","article-title":"Observational study mortality in treated primary aldosteronism: the German Conn\u2019s registry","volume":"60","author":"Reincke","year":"2012","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0124","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1001\/jamacardio.2018.2003","article-title":"Incidence of atrial fibrillation and mineralocorticoid receptor activity in patients with medically and surgically treated primary aldosteronism","volume":"3","author":"Hundemer","year":"2018","journal-title":"JAMA Cardiol"},{"key":"2026041420042985500_CIT0125","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","article-title":"Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study","volume":"6","author":"Hundemer","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026041420042985500_CIT0126","doi-asserted-by":"crossref","first-page":"32103","DOI":"10.1038\/srep32103","article-title":"Long term outcome of aldosteronism after target treatments","volume":"6","author":"Wu","year":"2016","journal-title":"Sci Rep"},{"key":"2026041420042985500_CIT0127","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1097\/00004872-199816121-00032","article-title":"Left ventricular systolic function in primary aldosteronism and hypertension","volume":"16","author":"Rossi","year":"1998","journal-title":"J Hypertens"},{"key":"2026041420042985500_CIT0128","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/01.HYP.27.5.1039","article-title":"Changes in left ventricular anatomy and function in hypertension and primary aldosteronism","volume":"27","author":"Rossi","year":"1996","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0129","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1161\/HYPERTENSIONAHA.117.10596","article-title":"Adrenalectomy lowers incident atrial fibrillation in primary aldosteronism patients at long term","volume":"71","author":"Rossi","year":"2018","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0130","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1161\/HYPERTENSIONAHA.117.10263","article-title":"Prevalence of cardiovascular disease and its risk factors in primary aldosteronism: a multicenter study in Japan","volume":"71","author":"Ohno","year":"2018","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0131","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/HYPERTENSIONAHA.113.01316","article-title":"Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism","volume":"62","author":"Rossi","year":"2013","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0132","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026041420042985500_CIT0133","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1681\/ASN.2004100878","article-title":"Relative glomerular hyperfiltration in primary aldosteronism","volume":"16","author":"Ribstein","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"2026041420042985500_CIT0134","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1210\/jc.2016-3867","article-title":"Renin phenotypes characterize vascular disease, autonomous aldosteronism, and mineralocorticoid receptor activity","volume":"102","author":"Hundemer","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0135","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1161\/HYPERTENSIONAHA.118.11568","article-title":"Renal outcomes in medically and surgically treated primary aldosteronism","volume":"72","author":"Hundemer","year":"2018","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0136","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1210\/jc.2008-1851","article-title":"Risk factors associated with a low glomerular filtration rate in primary aldosteronism","volume":"94","author":"Reincke","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0137","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.HYP.0000230444.01215.6a","article-title":"Renal damage in primary aldosteronism: results of the PAPY Study","volume":"48","author":"Rossi","year":"2006","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0138","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1001\/jama.295.22.2638","article-title":"Long-term renal outcomes in patients with primary aldosteronism","volume":"295","author":"Sechi","year":"2006","journal-title":"JAMA"},{"key":"2026041420042985500_CIT0139","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1097\/HJH.0b013e3283495cbb","article-title":"Primary aldosteronism: changes in cystatin C-based kidney filtration, proteinuria, and renal duplex indices with treatment","volume":"29","author":"Wu","year":"2011","journal-title":"J Hypertens"},{"key":"2026041420042985500_CIT0140","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.ekir.2020.06.012","article-title":"Associations between changes in plasma renin activity and aldosterone concentrations and changes in kidney function after treatment for primary aldosteronism","volume":"5","author":"Kobayashi","year":"2020","journal-title":"Kidney Int Rep"},{"key":"2026041420042985500_CIT0141","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/HJH.0000000000002216","article-title":"Renal damage in primary aldosteronism: a systematic review and meta-analysis","volume":"38","author":"Monticone","year":"2020","journal-title":"J Hypertens"},{"key":"2026041420042985500_CIT0142","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93136","article-title":"Steroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism","volume":"2","author":"Arlt","year":"2017","journal-title":"JCI Insight"},{"key":"2026041420042985500_CIT0143","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11845-013-1007-x","article-title":"Elevated prevalence of abnormal glucose metabolism in patients with primary aldosteronism: a meta-analysis","volume":"183","author":"Chen","year":"2014","journal-title":"Ir J Med Sci"},{"key":"2026041420042985500_CIT0144","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1530\/EJE-15-0450","article-title":"Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn\u2019s Registry","volume":"173","author":"Hanslik","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"2026041420042985500_CIT0145","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1210\/jc.2005-1733","article-title":"Prevalence and characteristics of the metabolic syndrome in primary aldosteronism","volume":"91","author":"Fallo","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0146","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1161\/HYPERTENSIONAHA.119.13922","article-title":"Primary aldosteronism decreases insulin secretion and increases insulin clearance in humans","volume":"75","author":"Adler","year":"2020","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0147","doi-asserted-by":"crossref","first-page":"363","DOI":"10.5664\/jcsm.27878","article-title":"Severity of obstructive sleep apnea is related to aldosterone status in subjects with resistant hypertension","volume":"6","author":"Gonzaga","year":"2010","journal-title":"J Clin Sleep Med"},{"key":"2026041420042985500_CIT0148","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1378\/chest.12-0802","article-title":"Increased dietary sodium is related to severity of obstructive sleep apnea in patients with resistant hypertension and hyperaldosteronism","volume":"143","author":"Pimenta","year":"2013","journal-title":"Chest"},{"key":"2026041420042985500_CIT0149","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1378\/chest.06-1442","article-title":"Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension","volume":"131","author":"Pratt-Ubunama","year":"2007","journal-title":"Chest"},{"key":"2026041420042985500_CIT0150","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/1470320310366581","article-title":"Renin-angiotensin-aldosterone system in patients with sleep apnoea: prevalence of primary aldosteronism","volume":"11","author":"Di Murro","year":"2010","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"2026041420042985500_CIT0151","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1161\/HYPERTENSIONAHA.120.16902","article-title":"Prospective screening for primary aldosteronism in patients with suspected obstructive sleep apnea","volume":"77","author":"Chee","year":"2021","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0152","doi-asserted-by":"crossref","first-page":"629","DOI":"10.5664\/jcsm.8960","article-title":"Primary aldosteronism is highly prevalent in patients with hypertension and moderate to severe obstructive sleep apnea","volume":"17","author":"Dobrowolski","year":"2021","journal-title":"J Clin Sleep Med"},{"key":"2026041420042985500_CIT0153","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1530\/EJE-17-0417","article-title":"Primary aldosteronism as a cause of secondary osteoporosis","volume":"177","author":"Salcuni","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"2026041420042985500_CIT0154","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1002\/jbmr.1660","article-title":"Bone involvement in aldosteronism","volume":"27","author":"Salcuni","year":"2012","journal-title":"J Bone Miner Res"},{"key":"2026041420042985500_CIT0155","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/jbmr.3033","article-title":"Risk of fracture in primary aldosteronism: a population-based cohort study","volume":"32","author":"Wu","year":"2017","journal-title":"J Bone Miner Res"},{"key":"2026041420042985500_CIT0156","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa123","article-title":"Disentangling the relationships between the renin-angiotensin-aldosterone system, calcium physiology, and risk for kidney stones","volume":"105","author":"Bayomy","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0157","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1161\/CIRCULATIONAHA.120.050896","article-title":"Association of serum aldosterone and plasma renin activity with ambulatory blood pressure in African Americans: the Jackson Heart Study","volume":"143","author":"Joseph","year":"2021","journal-title":"Circulation"},{"key":"2026041420042985500_CIT0158","doi-asserted-by":"crossref","first-page":"e023082","DOI":"10.1161\/JAHA.121.023082","article-title":"Heightened cardiovascular risk in hypertension associated with renin-independent aldosteronism versus renin-dependent aldosteronism: a collaborative study","volume":"10","author":"Hu","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2026041420042985500_CIT0159","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.122.19134","article-title":"Cardiac structure and function across the spectrum of aldosteronism: the atherosclerosis risk in communities study","author":"Brown","year":"2022","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0160","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1161\/HYPERTENSIONAHA.114.03231","article-title":"Aldosterone dysregulation with aging predicts renal vascular function and cardiovascular risk","volume":"63","author":"Brown","year":"2014","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0161","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehac352","article-title":"Aldosterone in chronic kidney disease and renal outcomes","author":"Verma","year":"2022","journal-title":"Eur Heart J"},{"key":"2026041420042985500_CIT0162","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society Clinical Practice Guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0163","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1097\/HJH.0000000000002510","article-title":"Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension","volume":"38","author":"Mulatero","year":"2020","journal-title":"J Hypertens"},{"key":"2026041420042985500_CIT0164","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S2213-8587(21)00210-2","article-title":"Diagnosis and treatment of primary aldosteronism","volume":"9","author":"Reincke","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026041420042985500_CIT0165","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1161\/HYPERTENSIONAHA.119.14359","article-title":"Screening rates for primary aldosteronism in resistant hypertension: a cohort study","volume":"75","author":"Jaffe","year":"2020","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0166","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.surg.2018.05.085","article-title":"Keeping primary aldosteronism in mind: deficiencies in screening at-risk hypertensives","volume":"165","author":"Ruhle","year":"2019","journal-title":"Surgery"},{"key":"2026041420042985500_CIT0167","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.surg.2019.05.087","article-title":"Adherence to consensus guidelines for screening of primary aldosteronism in an urban healthcare system","volume":"167","author":"Sivarajah","year":"2020","journal-title":"Surgery"},{"key":"2026041420042985500_CIT0168","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2021.0254","article-title":"Outcomes of a specialized clinic on rates of investigation and treatment of primary aldosteronism","author":"Liu","year":"2021","journal-title":"JAMA Surg"},{"key":"2026041420042985500_CIT0169","doi-asserted-by":"crossref","first-page":"289","DOI":"10.7326\/M20-4873","article-title":"Testing for primary aldosteronism and mineralocorticoid receptor antagonist use among U.S. veterans: a retrospective cohort study","volume":"174","author":"Cohen","year":"2021","journal-title":"Ann Intern Med"},{"key":"2026041420042985500_CIT0170","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1161\/HYPERTENSIONAHA.121.18118","article-title":"Screening rates for primary aldosteronism among individuals with hypertension plus hypokalemia: a population-based retrospective cohort study","volume":"79","author":"Hundemer","year":"2022","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0171","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/jamasurg.2021.0254","article-title":"Outcomes of a specialized clinic on rates of investigation and treatment of primary aldosteronism","volume":"156","author":"Liu","year":"2021","journal-title":"JAMA Surg"},{"key":"2026041420042985500_CIT0172","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1016\/j.jacc.2019.09.057","article-title":"Primary aldosteronism: JACC state-of-the-art review","volume":"74","author":"Rossi","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026041420042985500_CIT0173","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1161\/HYPERTENSIONAHA.111.00662","article-title":"Abnormal aldosterone physiology and cardiometabolic risk factors","volume":"61","author":"Vaidya","year":"2013","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0174","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1210\/clinem\/dgab348","article-title":"Performance of the aldosterone to renin ratio as a screening test for primary aldosteronism","volume":"106","author":"Hung","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0175","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa080","article-title":"Effects of mineralocorticoid and AT1 receptor antagonism on the aldosterone-renin ratio in primary aldosteronism-the EMIRA study","volume":"105","author":"Rossi","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0176","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1210\/jc.2018-01299","article-title":"Adrenal vein sampling lateralization despite mineralocorticoid receptor antagonists exposure in primary aldosteronism","volume":"104","author":"Nanba","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0177","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society Clinical Practice Guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0178","doi-asserted-by":"crossref","first-page":"e3655","DOI":"10.1210\/clinem\/dgab290","article-title":"Mineralocorticoid receptor antagonist effect on aldosterone to renin ratio in patients with primary aldosteronism","volume":"106","author":"Pecori","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0179","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1210\/jc.2018-01041","article-title":"Aldosterone LC-MS\/MS assay-specific threshold values in screening and confirmatory testing for primary aldosteronism","volume":"103","author":"Guo","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0180","doi-asserted-by":"crossref","first-page":"e477","DOI":"10.1210\/clinem\/dgz150","article-title":"Diagnosis of primary aldosteronism by seated saline suppression test - variability between immunoassay and HPLC-MS\/MS","volume":"105","author":"Thuzar","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0181","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgab924","article-title":"The saline infusion test for primary aldosteronism: implications of immunoassay inaccuracy","author":"Eisenhofer","year":"2022; 6:1\u20139","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0182","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1097\/HJH.0000000000001735","article-title":"Criteria for diagnosing primary aldosteronism on the basis of liquid chromatography-tandem mass spectrometry determinations of plasma aldosterone concentration","volume":"36","author":"Baron","year":"2018","journal-title":"J Hypertens"},{"key":"2026041420042985500_CIT0183","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.clinms.2018.06.002","article-title":"Migration from RIA to LC-MS\/MS for aldosterone determination: implications for clinical practice and determination of plasma and urine reference range intervals in a cohort of healthy Belgian subjects","volume":"9","author":"Le Goff","year":"2018","journal-title":"Clin Mass Spectrom"},{"key":"2026041420042985500_CIT0184","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1530\/EJE-20-0073","article-title":"Confirmatory testing of primary aldosteronism with saline infusion test and LC-MS\/MS","volume":"184","author":"Fuss","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"2026041420042985500_CIT0185","doi-asserted-by":"crossref","first-page":"EJ21-0278","DOI":"10.1507\/endocrj.EJ21-0278","article-title":"Comparison and commutability study between standardized liquid chromatography-mass spectrometry\/mass spectrometry (LC-MS\/MS) and chemiluminescent enzyme immunoassay for aldosterone measurement in blood","volume":"69","author":"Nishikawa","year":"2022","journal-title":"Endocr J"},{"key":"2026041420042985500_CIT0186","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics11030433","article-title":"Development of a new chemiluminescent enzyme immunoassay using a two-step sandwich method for measuring aldosterone concentrations","volume":"11","author":"Ozeki","year":"2021","journal-title":"Diagnostics"},{"key":"2026041420042985500_CIT0187","article-title":"Comparison of three different chemiluminescence assays and a rapid liquid chromatography tandem mass spectrometry method for measuring serum aldosterone","author":"Yin","journal-title":"Clin Chem Lab Med"},{"key":"2026041420042985500_CIT0188","article-title":"Recalibrating interpretations of aldosterone assays across the physiologic range: immunoassay and liquid chromatography\u2013tandem mass spectrometry measurements under multiple controlled conditions","volume":"6","author":"Brown","year":"2022","journal-title":"J Endocr Soc"},{"key":"2026041420042985500_CIT0189","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/ajh\/hpaa151","article-title":"Variability of aldosterone measurements during adrenal venous sampling for primary aldosteronism","volume":"34","author":"Yozamp","year":"2021","journal-title":"Am J Hypertens"},{"key":"2026041420042985500_CIT0190","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1530\/EJE-20-0030","article-title":"Prospective evaluation of aldosterone LC-MS\/ MS-specific cutoffs for the saline infusion test","volume":"183","author":"Fries","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"2026041420042985500_CIT0191","article-title":"Temporal pattern of renin and aldosterone secretion in men: effects of sodium balance","volume":"262:F871\u2013F877","author":"Vieweg","year":"1992","journal-title":"Am J Physiol Renal Physiol"},{"key":"2026041420042985500_CIT0192","first-page":"28","article-title":"Increased disorderliness and amplified basal and pulsatile aldosterone secretion in patients with primary aldosteronism","volume":"80","author":"Siragy","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0193","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1210\/jc.2002-021476","article-title":"Variability in the renin\/aldosterone profile under random and standardized sampling conditions in primary aldosteronism","volume":"88","author":"Tanabe","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0194","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/HJH.0000000000001905","article-title":"Surprisingly low aldosterone levels in peripheral veins following intravenous sedation during adrenal vein sampling: implications for the concept of nonsuppressibility in primary aldosteronism","volume":"37","author":"Kline","year":"2019","journal-title":"J Hypertens"},{"key":"2026041420042985500_CIT0195","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/HYPERTENSIONAHA.120.16429","article-title":"Intraindividual variability of aldosterone concentrations in primary aldosteronism: implications for case detection","volume":"77","author":"Yozamp","year":"2021","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0196","doi-asserted-by":"crossref","first-page":"e3969","DOI":"10.1210\/clinem\/dgab420","article-title":"ACTH stimulation maximizes the accuracy of peripheral steroid profiling in primary aldosteronism subtyping","volume":"106","author":"Tezuka","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0197","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1530\/EJE-16-0003","article-title":"A new highly sensitive and specific overnight combined screening and diagnostic test for primary aldosteronism","volume":"175","author":"Tsiavos","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"2026041420042985500_CIT0198","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJMoa1504869","article-title":"Pregnancy, primary aldosteronism, and adrenal CTNNB1 mutations","volume":"373","author":"Teo","year":"2015","journal-title":"N Engl J Med"},{"key":"2026041420042985500_CIT0199","first-page":"212627","article-title":"Impact of intraprocedural sedation on adrenal vein sampling without corticotropin stimulation","author":"Yang","year":"2022","journal-title":"Radiology"},{"key":"2026041420042985500_CIT0200","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1210\/jc.2018-01394","article-title":"Comparison of seated with recumbent saline suppression testing for the diagnosis of primary aldosteronism","volume":"103","author":"Stowasser","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0201","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1210\/clinem\/dgz148","article-title":"Role of Aldosterone and potassium levels in sparing confirmatory tests in primary aldosteronism","volume":"105","author":"Umakoshi","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0202","doi-asserted-by":"crossref","first-page":"e2449","DOI":"10.1210\/clinem\/dgaa282","article-title":"Development and validation of criteria for sparing confirmatory tests in diagnosing primary aldosteronism","volume":"105","author":"Wang","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0203","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1055\/s-0031-1295460","article-title":"Factors affecting the aldosterone\/renin ratio","volume":"44","author":"Stowasser","year":"2012","journal-title":"Horm Metab Res"},{"key":"2026041420042985500_CIT0204","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(15)00257-3","article-title":"Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial","volume":"386","author":"Williams","year":"2015","journal-title":"Lancet"},{"key":"2026041420042985500_CIT0205","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.122.19159","article-title":"Mineralocorticoid receptor antagonists cause natriuresis in the absence of aldosterone","author":"Maeoka","year":"2022","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0206","doi-asserted-by":"crossref","first-page":"e866","DOI":"10.1210\/clinem\/dgaa812","article-title":"Significance of discordant results between confirmatory tests in diagnosis of primary aldosteronism","volume":"106","author":"Fukumoto","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0207","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.122.19377","article-title":"Performance of confirmatory tests for diagnosing primary aldosteronism: a systematic review and meta-analysis","author":"Leung","year":"2022","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0208","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1210\/clinem\/dgaa606","article-title":"Evolution of the primary aldosteronism syndrome: updating the approach","volume":"105","author":"Vaidya","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0209","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1161\/HYPERTENSIONAHA.120.16585","article-title":"Primary aldosteronism: three strikes and out","volume":"77","author":"Funder","year":"2021","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0210","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/BF01476798","article-title":"Evidence for a subgroup of essential hypertensives with non-suppressible excretion of aldosterone during sodium loading","volume":"58","author":"Helber","year":"1980","journal-title":"Klin Wochenschr"},{"key":"2026041420042985500_CIT0211","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1161\/HYPERTENSIONAHA.120.15328","article-title":"Presence of subclinical hypercortisolism in clinical aldosterone-producing adenomas predicts lower clinical success","volume":"76","author":"Peng","year":"2020","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0212","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1210\/jc.2019-00299","article-title":"Impaired glucose metabolism in primary aldosteronism is associated with cortisol cosecretion","volume":"104","author":"Gerards","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0213","doi-asserted-by":"crossref","first-page":"938","DOI":"10.2337\/dc18-1293","article-title":"High prevalence of diabetes in patients with primary aldosteronism (PA) associated with subclinical hypercortisolism and prediabetes more prevalent in bilateral than unilateral PA: a large, multicenter cohort study in Japan","volume":"42","author":"Akehi","year":"2019","journal-title":"Diabetes Care"},{"key":"2026041420042985500_CIT0214","doi-asserted-by":"crossref","first-page":"e2423","DOI":"10.1210\/clinem\/dgab099","article-title":"Autonomous cortisol secretion influences psychopathological symptoms in patients with primary aldosteronism","volume":"106","author":"Gendreitzig","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0215","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1530\/EJE-21-1131","article-title":"Primary aldosteronism with mild autonomous cortisol secretion increases renal complication risk","volume":"186","author":"Katabami","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"2026041420042985500_CIT0216","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jc.2019-00996","article-title":"Adrenal insufficiency after unilateral adrenalectomy in primary aldosteronism: long-term outcome and clinical impact","volume":"104","author":"Heinrich","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0217","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa519","article-title":"Low-grade cortisol cosecretion has limited impact on ACTH-stimulated AVS parameters in primary aldosteronism","volume":"105","author":"O\u2019Toole","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0218","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1210\/clinem\/dgab512","article-title":"Approach to the patient with adrenal incidentaloma","volume":"106","author":"Bancos","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0219","doi-asserted-by":"crossref","first-page":"178","DOI":"10.4158\/DSCR-2018-0565","article-title":"The evaluation of incidentally discovered adrenal masses","volume":"25","author":"Vaidya","year":"2019","journal-title":"Endocr Pract"},{"key":"2026041420042985500_CIT0220","first-page":"564","article-title":"Primary aldosteronism associated with subclinical Cushing syndrome","volume":"36","author":"Fujimoto","year":"2013","journal-title":"J Endocrinol Invest"},{"key":"2026041420042985500_CIT0221","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1097\/HJH.0b013e32834937f3","article-title":"Concurrent primary aldosteronism and subclinical cortisol hypersecretion: a prospective study","volume":"29","author":"Fallo","year":"2011","journal-title":"J Hypertens"},{"key":"2026041420042985500_CIT0222","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1507\/endocrj.K10E-402","article-title":"Clinicopathological features of primary aldosteronism associated with subclinical Cushing\u2019s syndrome","volume":"58","author":"Hiraishi","year":"2011","journal-title":"Endocr J"},{"key":"2026041420042985500_CIT0223","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1097\/HJH.0b013e3283635789","article-title":"Adrenal reserve function after unilateral adrenalectomy in patients with primary aldosteronism","volume":"31","author":"Honda","year":"2013","journal-title":"J Hypertens"},{"key":"2026041420042985500_CIT0224","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1210\/jc.2018-00617","article-title":"Cortisol excess in patients with primary aldosteronism impacts left ventricular hypertrophy","volume":"103","author":"Adolf","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0225","doi-asserted-by":"crossref","DOI":"10.1530\/EJE-21-1157","article-title":"Autonomous cortisol secretion is associated with worse arterial stiffness and vascular fibrosis in primary aldosteronism - a cross-sectional study with follow-up data","author":"Tsai","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"2026041420042985500_CIT0226","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1210\/clinem\/dgab698","article-title":"Selective glucocorticoid replacement following unilateral adrenalectomy for hypercortisolism and primary aldosteronism","volume":"107","author":"DeLozier","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0227","doi-asserted-by":"crossref","DOI":"10.1093\/ajh\/hpab189","article-title":"Morphologically normal-appearing adrenal glands as a prevalent source of aldosterone production in primary aldosteronism","author":"Parksook","year":"2022; 35:561\u2013571","journal-title":"Am J Hypertens"},{"key":"2026041420042985500_CIT0228","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1210\/jc.2011-2830","article-title":"The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism","volume":"97","author":"Rossi","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0229","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-151-5-200909010-00007","article-title":"Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism","volume":"151","author":"Kempers","year":"2009","journal-title":"Ann Intern Med"},{"key":"2026041420042985500_CIT0230","doi-asserted-by":"crossref","first-page":"e038489","DOI":"10.1136\/bmjopen-2020-038489","article-title":"Diagnostic accuracy of adrenal imaging for subtype diagnosis in primary aldosteronism: systematic review and meta-analysis","volume":"10","author":"Zhou","year":"2020","journal-title":"BMJ Open"},{"key":"2026041420042985500_CIT0231","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1210\/jc.2017-01774","article-title":"Significance of computed tomography and serum potassium in predicting subtype diagnosis of primary aldosteronism","volume":"103","author":"Umakoshi","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0232","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.eprac.2020.10.007","article-title":"Prevalence, subtype classification, and outcomes of treatment of primary aldosteronism: a prospective study in China","volume":"27","author":"Xu","year":"2021","journal-title":"Endocr Pract"},{"key":"2026041420042985500_CIT0233","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1161\/HYPERTENSIONAHA.118.11382","article-title":"Computed tomography and adrenal venous sampling in the diagnosis of unilateral primary aldosteronism","volume":"72","author":"Williams","year":"2018","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0234","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1210\/jc.2018-02089","article-title":"Discordance between imaging and adrenal vein sampling in primary aldosteronism irrespective of interpretation criteria","volume":"104","author":"Sam","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0235","doi-asserted-by":"crossref","first-page":"e4340","DOI":"10.1210\/clinem\/dgab482","article-title":"Identification of surgically curable primary aldosteronism by imaging in a large, multiethnic International study","volume":"106","author":"Rossi","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0236","doi-asserted-by":"crossref","DOI":"10.1507\/endocrj.EJ21-0508","article-title":"Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021","author":"Naruse","year":"2022","journal-title":"Endocr J"},{"key":"2026041420042985500_CIT0237","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jfma.2017.06.004","article-title":"Case detection and diagnosis of primary aldosteronism\u2014the consensus of Taiwan Society of Aldosteronism","volume":"116","author":"Wu","year":"2017","journal-title":"J Formos Med Assoc"},{"key":"2026041420042985500_CIT0238","doi-asserted-by":"crossref","first-page":"e2087","DOI":"10.1210\/clinem\/dgab047","article-title":"Adrenal venous sampling in young patients with primary aldosteronism. extravagance or irreplaceable?","volume":"106","author":"Gkaniatsa","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0239","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/cen.13582","article-title":"Accuracy of adrenal computed tomography in predicting the unilateral subtype in young patients with hypokalaemia and elevation of aldosterone in primary aldosteronism","volume":"88","author":"Umakoshi","year":"2018","journal-title":"Clin Endocrinol"},{"key":"2026041420042985500_CIT0240","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1161\/HYPERTENSIONAHA.121.18284","article-title":"Feasibility of imaging-guided adrenalectomy in young patients with primary aldosteronism","volume":"79","author":"Rossi","year":"2022","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0241","doi-asserted-by":"crossref","first-page":"e1170","DOI":"10.1210\/clinem\/dgaa930","article-title":"Repeat adrenal vein sampling in aldosteronism: reproducibility and interpretation of persistently discordant results","volume":"106","author":"Kline","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0242","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/HJH.0000000000001564","article-title":"The subtyping of primary aldosteronism by adrenal vein sampling: sequential blood sampling causes factitious lateralization","volume":"36","author":"Rossitto","year":"2018","journal-title":"J Hypertens"},{"key":"2026041420042985500_CIT0243","article-title":"Adrenal venous sampling with or without adrenocorticotropic hormone stimulation: a meta-analysis","author":"Laurent","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0244","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/HJH.0000000000001964","article-title":"Impact of adrenocorticotropic hormone stimulation during adrenal venous sampling on outcomes of primary aldosteronism","volume":"37","author":"Takeda","year":"2019","journal-title":"J Hypertens"},{"key":"2026041420042985500_CIT0245","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1161\/HYPERTENSIONAHA.121.17248","article-title":"Adrenocorticotropic hormone-stimulated adrenal venous sampling underestimates surgically curable primary aldosteronism: a retrospective cohort study and review of contemporary studies","volume":"78","author":"Yozamp","year":"2021","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0246","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz017","article-title":"Subtyping of primary aldosteronism in the AVIS-2 study: assessment of selectivity and lateralization","volume":"105","author":"Rossitto","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0247","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00270-021-02954-7","article-title":"Does intraprocedural CT improve the success rate of adrenal venous sampling? A systematic review and meta-analysis of data from 809 patients","volume":"45","author":"Hafezi-Nejad","year":"2022","journal-title":"Cardiovasc Intervent Radiol"},{"key":"2026041420042985500_CIT0248","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s00270-014-0969-z","article-title":"Image registration of cone-beam computer tomography and preprocedural computer tomography aids in localization of adrenal veins and decreasing radiation dose in adrenal vein sampling","volume":"38","author":"Busser","year":"2015","journal-title":"Cardiovasc Intervent Radiol"},{"key":"2026041420042985500_CIT0249","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.jvir.2011.05.005","article-title":"Intraprocedural cortisol levels in the evaluation of proper catheter placement in adrenal venous sampling","volume":"22","author":"Reardon","year":"2011","journal-title":"J Vasc Interv Radiol"},{"key":"2026041420042985500_CIT0250","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1055\/a-1535-2566","article-title":"Reduction of radiation exposure in adrenal vein sampling: impact of the rapid cortisol assay [Reduktion der Strahlenbelastung bei der selektiven Nebennierenvenenblutentnahme: Einfluss des Kortison-Schnelltests]","volume":"193","author":"Augustin","year":"2021","journal-title":"Rofo"},{"key":"2026041420042985500_CIT0251","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/HJH.0000000000001693","article-title":"Application of strict criteria in adrenal venous sampling increases the proportion of missed patients with unilateral disease who benefit from surgery for primary aldosteronism","volume":"36","author":"Kline","year":"2018","journal-title":"J Hypertens"},{"key":"2026041420042985500_CIT0252","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1161\/HYPERTENSIONAHA.113.02097","article-title":"An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism","volume":"63","author":"Rossi","year":"2014","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0253","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/cen.14546","article-title":"Apparent failed and discordant adrenal vein sampling: a potential confounding role of cortisol cosecretion?","volume":"96","author":"Kline","year":"2022","journal-title":"Clin Endocrinol"},{"key":"2026041420042985500_CIT0254","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2213-8587(16)30100-0","article-title":"Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial","volume":"4","author":"Dekkers","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026041420042985500_CIT0255","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1161\/HYPERTENSIONAHA.116.08820","article-title":"Adrenal venous sampling versus computed tomographic scan to determine treatment in primary aldosteronism (The SPARTACUS Trial): a critique","volume":"69","author":"Rossi","year":"2017","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0256","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1161\/HYPERTENSIONAHA.119.13463","article-title":"Clinical outcomes of 1625 patients with primary aldosteronism subtyped with adrenal vein sampling","volume":"74","author":"Rossi","year":"2019","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0257","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1055\/a-0713-0629","article-title":"Inherited forms of primary hyperaldosteronism: new genes, new phenotypes and proposition of a new classification","volume":"127","author":"Perez-Rivas","year":"2019","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2026041420042985500_CIT0258","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1177\/000313480006601005","article-title":"Laparoscopic adrenalectomy is superior to an open approach to treat primary hyperaldosteronism","volume":"66","author":"Duncan","year":"2000","journal-title":"Am Surg"},{"key":"2026041420042985500_CIT0259","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0022-5347(05)64028-1","article-title":"Laparoscopic management of primary hyperaldosteronism: clinical experience with 212 cases","volume":"169","author":"Meria","year":"2003","journal-title":"J Urol"},{"key":"2026041420042985500_CIT0260","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/000313480206800307","article-title":"Primary hyperaldosteronism in the era of laparoscopic adrenalectomy","volume":"68","author":"Rossi","year":"2002","journal-title":"Am Surg"},{"key":"2026041420042985500_CIT0261","first-page":"1995","article-title":"Laparoscopic versus open adrenalectomy for surgical adrenal disease","volume":"10","author":"Jacobsen","year":"2003","journal-title":"Can J Urol"},{"key":"2026041420042985500_CIT0262","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1530\/EJE-20-0254","article-title":"Basal contralateral aldosterone suppression is rare in lateralized primary aldosteronism","volume":"183","author":"Desrochers","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"2026041420042985500_CIT0263","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort","volume":"5","author":"Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026041420042985500_CIT0264","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1097\/HJH.0000000000002070","article-title":"Clinical and biochemical outcomes after adrenalectomy and medical treatment in patients with unilateral primary aldosteronism","volume":"37","author":"Katabami","year":"2019","journal-title":"J Hypertens"},{"key":"2026041420042985500_CIT0265","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.surg.2017.10.045","article-title":"Analysis of postoperative biochemical values and clinical outcomes after adrenalectomy for primary aldosteronism","volume":"163","author":"Swearingen","year":"2018","journal-title":"Surgery"},{"key":"2026041420042985500_CIT0266","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00268-019-05265-8","article-title":"Outcomes after surgery for unilateral dominant primary aldosteronism in Sweden","volume":"44","author":"Sellgren","year":"2020","journal-title":"World J Surg"},{"key":"2026041420042985500_CIT0267","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.surg.2020.07.046","article-title":"Long-term outcome success after operative treatment for primary aldosteronism","volume":"169","author":"Picado","year":"2021","journal-title":"Surgery"},{"key":"2026041420042985500_CIT0268","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/cen.14176","article-title":"Appropriate timing for a biochemical evaluation after adrenalectomy for unilateral aldosterone-producing adenoma","volume":"92","author":"Takamatsu","year":"2020","journal-title":"Clin Endocrinol"},{"key":"2026041420042985500_CIT0269","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s002689900552","article-title":"Success of surgery for primary aldosteronism judged by residual autonomous aldosterone production","volume":"22","author":"Rutherford","year":"1998","journal-title":"World J Surg"},{"key":"2026041420042985500_CIT0270","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1067\/msy.1998.93108","article-title":"Essential hypertension: first reason for persistent hypertension after unilateral adrenalectomy for primary aldosteronism?","volume":"124","author":"Proye","year":"1998","journal-title":"Surgery"},{"key":"2026041420042985500_CIT0271","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1210\/jc.2009-1763","article-title":"Improved quality of life, blood pressure, and biochemical status following laparoscopic adrenalectomy for unilateral primary aldosteronism","volume":"95","author":"Sukor","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0272","doi-asserted-by":"crossref","first-page":"e185842","DOI":"10.1001\/jamasurg.2018.5842","article-title":"Clinical outcomes after unilateral adrenalectomy for primary aldosteronism","author":"Vorselaars","year":"2019","journal-title":"JAMA Surg"},{"key":"2026041420042985500_CIT0273","first-page":"277","article-title":"Clinical outcomes following unilateral adrenalectomy in patients with primary aldosteronism","volume":"110","author":"Hannon","year":"2017","journal-title":"QJM"},{"key":"2026041420042985500_CIT0274","doi-asserted-by":"crossref","first-page":"258","DOI":"10.7326\/0003-4819-135-4-200108210-00010","article-title":"Primary aldosteronism: factors associated with normalization of blood pressure after surgery","volume":"135","author":"Sawka","year":"2001","journal-title":"Ann Intern Med"},{"key":"2026041420042985500_CIT0275","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1001\/archsurg.1996.01430180072015","article-title":"Factors influencing outcome of surgery for primary aldosteronism","volume":"131","author":"Celen","year":"1996","journal-title":"Arch Surg"},{"key":"2026041420042985500_CIT0276","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1053\/j.ajkd.2009.06.014","article-title":"Association of kidney function with residual hypertension after treatment of aldosterone-producing adenoma","volume":"54","author":"Group","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"2026041420042985500_CIT0277","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1530\/EJE-21-0018","article-title":"Renin, a marker for left ventricular hypertrophy, in primary aldosteronism: a cohort study","volume":"185","author":"Kohler","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"2026041420042985500_CIT0278","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1210\/js.2019-00019","article-title":"Adrenalectomy improves the long-term risk of end-stage renal disease and mortality of primary aldosteronism","volume":"3","author":"Chen","year":"2019","journal-title":"J Endocr Soc"},{"key":"2026041420042985500_CIT0279","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1161\/HYPERTENSIONAHA.119.13131","article-title":"Association between acute fall in estimated glomerular filtration rate after treatment for primary aldosteronism and long-term decline in renal function","volume":"74","author":"Kobayashi","year":"2019","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0280","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1097\/HJH.0000000000001361","article-title":"Risk of new-onset diabetes mellitus in primary aldosteronism: a population study over 5 years","volume":"35","author":"Wu","year":"2017","journal-title":"J Hypertens"},{"key":"2026041420042985500_CIT0281","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1210\/jc.2011-0138","article-title":"Quality of life in patients with bilateral primary aldosteronism before and during treatment with spironolactone and\/or amiloride, including a comparison with our previously published results in those with unilateral disease treated surgically","volume":"96","author":"Ahmed","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0282","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/jc.2017-01442","article-title":"Quality of life in primary aldosteronism: a comparative effectiveness study of adrenalectomy and medical treatment","volume":"103","author":"Velema","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0283","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12893-018-0432-1","article-title":"Effect of unilateral adrenalectomy on the quality of life of patients with lateralized primary aldosteronism","volume":"18","author":"Citton","year":"2019","journal-title":"BMC Surg"},{"key":"2026041420042985500_CIT0284","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1530\/EJE-21-0836","article-title":"Long-term mortality and cardiovascular events in patients with unilateral primary aldosteronism after targeted treatments","volume":"186","author":"Wu","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"2026041420042985500_CIT0285","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1148\/radiol.2016152277","article-title":"Aldosterone-producing adenoma in primary aldosteronism: CT-guided radiofrequency ablation-long-term results and recurrence rate","volume":"281","author":"Liu","year":"2016","journal-title":"Radiology"},{"key":"2026041420042985500_CIT0286","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/HJH.0000000000002708","article-title":"Radiofrequency ablation for adenoma in patients with primary aldosteronism and hypertension: ADERADHTA, a pilot study","volume":"39","author":"Bouhanick","year":"2021","journal-title":"J Hypertens"},{"key":"2026041420042985500_CIT0287","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/CIRCULATIONAHA.121.054318","article-title":"Catheter-based adrenal ablation remits primary aldosteronism: a randomized medication-controlled trial","volume":"144","author":"Zhao","year":"2021","journal-title":"Circulation"},{"key":"2026041420042985500_CIT0288","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/jch.13960","article-title":"Adrenal artery ablation for primary aldosteronism without apparent aldosteronoma: an efficacy and safety, proof-of-principle trial","volume":"22","author":"Zhang","year":"2020","journal-title":"J Clin Hypertens"},{"key":"2026041420042985500_CIT0289","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jvir.2016.03.042","article-title":"Clinical outcomes following percutaneous radiofrequency ablation of unilateral aldosterone-producing adenoma: comparison with adrenalectomy","volume":"27","author":"Sarwar","year":"2016","journal-title":"J Vasc Interv Radiol"},{"key":"2026041420042985500_CIT0290","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N Engl J Med"},{"key":"2026041420042985500_CIT0291","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular events with finerenone in kidney disease and type 2 diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"N Engl J Med"},{"key":"2026041420042985500_CIT0292","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1161\/HYPERTENSIONAHA.121.17073","article-title":"Effect of KBP-5074 on blood pressure in advanced chronic kidney disease: results of the BLOCK-CKD study","volume":"78","author":"Bakris","year":"2021","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0293","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1097\/HJH.0000000000001088","article-title":"Guidelines for primary aldosteronism: uptake by primary care physicians in Europe","volume":"34","author":"Mulatero","year":"2016","journal-title":"J Hypertens"},{"key":"2026041420042985500_CIT0294","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S2213-8587(18)30071-8","article-title":"Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies","volume":"6","author":"Williams","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026041420042985500_CIT0295","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/S0140-6736(19)32135-X","article-title":"Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial","volume":"394","author":"Agarwal","year":"2019","journal-title":"Lancet"},{"key":"2026041420042985500_CIT0296","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.2022020207","article-title":"Albuminuria-lowering effect of dapagliflozin, eplerenone, and their combination in patients with chronic kidney disease: a randomized cross-over clinical trial","author":"Provenzano","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"2026041420042985500_CIT0297","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000173955","article-title":"Adrenalectomy in primary aldosteronism: a long-term follow-up study","volume":"72","author":"Groth","year":"1985","journal-title":"Cardiology"},{"key":"2026041420042985500_CIT0298","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1210\/jc.2008-2803","article-title":"Role of unilateral adrenalectomy in bilateral primary aldosteronism: a 22-year single center experience","volume":"94","author":"Sukor","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0299","doi-asserted-by":"crossref","first-page":"R183","DOI":"10.1530\/EJE-20-0863","article-title":"Management of Endocrine Disease: the role of surgical adrenalectomy in primary aldosteronism","volume":"183","author":"Hundemer","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"2026041420042985500_CIT0300","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1210\/jc.2011-1537","article-title":"Evaluation of the sensitivity and specificity of (11)C-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by Conn\u2019s adenomas","volume":"97","author":"Burton","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0301","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/cen.13942","article-title":"(11)C-Metomidate PET\/CT is a useful adjunct for lateralization of primary aldosteronism in routine clinical practice","volume":"90","author":"O\u2019Shea","year":"2019","journal-title":"Clin Endocrinol"},{"key":"2026041420042985500_CIT0302","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1530\/EJE-20-0532","article-title":"Functional imaging with 11C-metomidate PET for subtype diagnosis in primary aldosteronism","volume":"183","author":"Soinio","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"2026041420042985500_CIT0303","doi-asserted-by":"crossref","first-page":"e2016209","DOI":"10.1001\/jamanetworkopen.2020.16209","article-title":"Use of steroid profiling combined with machine learning for identification and subtype classification in primary aldosteronism","volume":"3","author":"Eisenhofer","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2026041420042985500_CIT0304","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1161\/HYPERTENSIONAHA.119.13866","article-title":"Comprehensive analysis of steroid biomarkers for guiding primary aldosteronism subtyping","volume":"75","author":"Turcu","year":"2020","journal-title":"Hypertension"},{"key":"2026041420042985500_CIT0305","doi-asserted-by":"crossref","first-page":"5867","DOI":"10.1210\/jc.2019-01182","article-title":"Three discrete patterns of primary aldosteronism lateralization in response to cosyntropin during adrenal vein sampling","volume":"104","author":"Wannachalee","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0306","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/ajh\/hpab195","article-title":"External validation of clinical prediction models in unilateral primary aldosteronism","volume":"35","author":"Sam","year":"2022","journal-title":"Am J Hypertens"},{"key":"2026041420042985500_CIT0307","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1097\/HJH.0000000000001855","article-title":"Development and validation of subtype prediction scores for the workup of primary aldosteronism","volume":"36","author":"Kobayashi","year":"2018","journal-title":"J Hypertens"},{"key":"2026041420042985500_CIT0308","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa379","article-title":"Development and validation of prediction models for subtype diagnosis of patients with primary aldosteronism","volume":"105","author":"Burrello","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2026041420042985500_CIT0309","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41440-020-00570-5","article-title":"Efficacy and safety of esaxerenone (CS-3150), a newly available nonsteroidal mineralocorticoid receptor blocker, in hypertensive patients with primary aldosteronism","volume":"44","author":"Satoh","year":"2021","journal-title":"Hypertens Res"}],"container-title":["American Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajh\/advance-article-pdf\/doi\/10.1093\/ajh\/hpac079\/46098408\/hpac079.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajh\/article-pdf\/35\/12\/967\/47707191\/hpac079.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajh\/article-pdf\/35\/12\/967\/47707191\/hpac079.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:07:35Z","timestamp":1776211655000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajh\/article\/35\/12\/967\/6620780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,29]]},"references-count":309,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,6,29]]},"published-print":{"date-parts":[[2022,12,8]]}},"URL":"https:\/\/doi.org\/10.1093\/ajh\/hpac079","relation":{},"ISSN":["0895-7061","1941-7225"],"issn-type":[{"value":"0895-7061","type":"print"},{"value":"1941-7225","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,12,1]]},"published":{"date-parts":[[2022,6,29]]}}}